December 2, 2021
“EDITOR’S NOTE: Jeremy Siegel, a professor at the prestigious University of Pennsylvania’s Wharton Business School, “told the assembled wealth managers at the Forbes/SHOOK Top Advisor Summit in Las Vegas that the current economic picture is unsustainable and projected 20% to… Continue Reading…
November 9, 2021
“The U.S. Federal Reserve warned Monday of potential spillover from China’s real estate troubles to the U.S. financial system. Since this summer, highly indebted developer China Evergrande has rattled global investors as the company has attempted to avoid official default. Other Chinese developers have also struggled… Continue Reading…
September 17, 2021
“More than 60 cryptocurrency exchanges in South Korea must notify customers of a partial or full suspension of trading by Friday midnight, a week before a new regulation comes into effect. To continue operating, exchanges must register with the Financial… Continue Reading…
September 16, 2021
“Dole Plc (DOLE)… Overall, the recent analyst reviews on DOLE, breaking down to 3 Buys, 1 Hold, and 1 Sell, give the stock a Moderate Buy consensus rating. Shares are priced at $14.87 and the average price target of $19.60 implies… Continue Reading…
September 9, 2021
“…Top Quality S&P 500 Stocks Members of Invesco S&P 500 Quality ETF up the most this year Name Ticker Stock YTD % Ch. 1-month % stock ch. Sector Fortinet (FTNT) 108.2% 1.8% Information Technology Generac Holdings (GNRC) 94.9 6.8 Industrials… Continue Reading…
August 2, 2021
“What happened: Shares of the world’s large produce company slid by over 9% on Friday after debuting on the New York Stock Exchange. Dole (NYSE: DOLE) opened for trading at $15, at an implied market value of approximately $1.5 billion, which was below the… Continue Reading…
July 23, 2021
“Shares of Indian food delivery start-up Zomato jumped as high as 82% during its market debut on Friday. The initial public offering price was set at 76 rupees a share and the stock opened 52.63% higher at 116 rupees on… Continue Reading…
July 19, 2021
“Ambrx Biopharma (AMAM)… This new biopharma stock has a Strong Buy rating from the analyst consensus, based on 3 positive reviews so far. The shares are priced at $19.56 and their $39.50 average target suggests room for an upside of 101%… Continue Reading…
June 22, 2021
“Paymentus Holdings (PAY)… Overall, PAY has received 8 recent analyst reviews, breaking down to 6 Buys versus 2 Holds and making the analyst consensus rating a Strong Buy. The stock has current trading price of $32.35 and an average price… Continue Reading…
Recent Comments